| This educational site for healthcare professionals may refer to drug classes where Teva has a product and/or Teva products. This educational site for healthcare professionals has been initiated and funded by Teva. Prescribing Information is available here. |
| Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0)207 540 7117, or email uk.safety@tevauk.com. |
Optimising the management, treatment and care for headache and migraine patients
Our Head Start programme activities are created by healthcare professionals, for healthcare professionals - designed for Consultants, Nurses, GPs and other healthcare professionals from the UK and Ireland with an interest in headache and migraine
Latest Updates
On Demand Recordings
Access on-demand recordings from Head Start's Annual Meeting 2024, presented by leading HCPs
Webinar: The migraine, anxiety and depression cycle: Could CGRP inhibitors break it?
To receive notification when this is added to our On Demand Recordings, sign up now
Head Start's Annual Meeting
Held in June 2024, you can access the highlights and review the topics covered below
Next event
Head Start Events in 2025
We're finalising our event and webinar schedule for 2025
To ensure you receive information about future events, register your email with Teva.
Head Start's Annual Meeting 2024
The sixth Head Start educational meeting focused on the latest advancements in headache and migraine management
On Demand Recordings
Access on-demand recordings from Head Start's Annual Meeting 2024
Agenda & Discussion Topics
Pertinent topics to gain deeper understanding of headache and migraine management strategies
Head Start meetings have been rated highly by previous delegates
100% would attend Head Start's Annual Meeting again*
81% rated the meeting as very successful in hitting their educational objectives*
Meeting was rated 4.9/5 in overall meeting satisfaction*
Reflections from Head Start's Annual Meeting 2024
Dr Krishna Dani, Consultant Neurologist, NHS Greater Glasgow and Clyde, shares his reflections after Head Start's Annual Meeting 2024
Reflections from Head Start's Annual Meeting 2024
Dr Krishna Dani, Consultant Neurologist, NHS Greater Glasgow and Clyde, shares his reflections after Head Start's Annual Meeting 2024
On Demand Recordings
Recordings of Head Start's Annual Meeting 2024 and other related content from Teva
Access on-demand recordings, covering a range of topics from various events, presented by leading healthcare professionals
*of the number of delegates who completed event feedback
This educational site for healthcare professionals has been initiated and funded by Teva.
Registered in England No. 302461. Registered office: Teva UK Limited, Ridings Point, Whistler Drive, Castleford, West Yorkshire, WF10 5HX
+44 (0) 1977 628500 | www.tevauk.com | Copyright © 2024 Teva UK Limited
Adverse events should be reported: Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (UK) or www.hpra.ie (ROI). Adverse events should also be reported to Teva using the Reporting Side Effects Form or telephone +44 (0) 207 540 7117, or email uk.safety@tevauk.com.
Privacy Policy | Pharmacovigilance Privacy Policy | Terms and Conditions | Accessibility | Reporting Adverse Events